HER2

Nicole Vincent Jordan1, Aditya Bardia1,2, Ben S Wittner1,2

  • 1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA.

Nature
|August 25, 2016
PubMed
概括

晚期乳腺癌细胞可以发展HER2阳性特征,导致药物耐药性. 针对 HER2 和 Notch 途径显示出抑制瘤生长的潜力.